Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase
- PMID: 17630785
- PMCID: PMC2596615
- DOI: 10.1021/bi700688x
Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase
Abstract
New approaches are required to combat Mycobacterium tuberculosis (Mtb), especially the multi-drug resistant and extremely drug resistant organisms (MDR-TB and XDR-TB). There are many reports that mycobacteria oxidize 3beta-hydroxysterols to 3-ketosteroids, but the enzymes responsible for this activity have not been identified in mycobacterial species. In this work, the Rv1106c gene that is annotated as a 3beta-hydroxysteroid dehydrogenase in Mtb has been cloned and heterologously expressed. The purified enzyme was kinetically characterized and found to have a pH optimum between 8.5 and 9.5. The enzyme, which is a member of the short chain dehydrogenase superfamily, uses NAD+ as a cofactor and oxidizes cholesterol, pregnenolone, and dehydroepiandrosterone to their respective 3-keto-4-ene products. The enzyme forms a ternary complex with NAD+ binding before the sterol. The enzyme shows no substrate preference for dehydroepiandrosterone versus pregnenolone with second-order rate constants (kcat/Km) of 3.2 +/- 0.4 and 3.9 +/- 0.9 microM-1 min-1, respectively, at pH 8.5, 150 mM NaCl, 30 mM MgCl2, and saturating NAD+. Trilostane is a competitive inhibitor of dehydroepiandrosterone with a Ki of 197 +/- 8 microM. The expression of the 3beta-hydroxysteroid dehydrogenase in Mtb is intracellular. Disruption of the 3beta-hydroxysteroid dehydrogenase gene in Mtb abrogates mycobacterial cholesterol oxidation activity. These data are consistent with the Rv1106c gene being the one responsible for 3beta-hydroxysterol oxidation in Mtb.
Figures








Similar articles
-
Cloning, prokaryotic expression and function of the Bufo bufo gargarizans 3β-hydroxysteroid dehydrogenase (3βHSD) gene.Int J Biol Macromol. 2018 Dec;120(Pt A):673-682. doi: 10.1016/j.ijbiomac.2018.08.165. Epub 2018 Aug 29. Int J Biol Macromol. 2018. PMID: 30170058
-
The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.J Steroid Biochem Mol Biol. 2010 Jun;120(4-5):192-9. doi: 10.1016/j.jsbmb.2010.04.015. Epub 2010 Apr 24. J Steroid Biochem Mol Biol. 2010. PMID: 20420909 Free PMC article.
-
Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.Bioorg Med Chem Lett. 2011 Apr 15;21(8):2216-9. doi: 10.1016/j.bmcl.2011.03.004. Epub 2011 Mar 6. Bioorg Med Chem Lett. 2011. PMID: 21439822 Free PMC article.
-
Microbial catabolism of sterols: focus on the enzymes that transform the sterol 3β-hydroxy-5-en into 3-keto-4-en.FEMS Microbiol Lett. 2017 Feb 1;364(3). doi: 10.1093/femsle/fnx007. FEMS Microbiol Lett. 2017. PMID: 28087615 Review.
-
DHEA and peripheral androgen and estrogen formation: intracinology.Ann N Y Acad Sci. 1995 Dec 29;774:16-28. doi: 10.1111/j.1749-6632.1995.tb17369.x. Ann N Y Acad Sci. 1995. PMID: 8597456 Review. No abstract available.
Cited by
-
Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.Front Cell Infect Microbiol. 2021 Jul 28;11:709972. doi: 10.3389/fcimb.2021.709972. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34395315 Free PMC article.
-
Cholesterol is not an essential source of nutrition for Mycobacterium tuberculosis during infection.J Bacteriol. 2011 Mar;193(6):1473-6. doi: 10.1128/JB.01210-10. Epub 2011 Jan 21. J Bacteriol. 2011. PMID: 21257778 Free PMC article.
-
Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities.ACS Infect Dis. 2019 Jul 12;5(7):1239-1251. doi: 10.1021/acsinfecdis.9b00099. Epub 2019 May 3. ACS Infect Dis. 2019. PMID: 31012313 Free PMC article.
-
Steroids as Environmental Compounds Recalcitrant to Degradation: Genetic Mechanisms of Bacterial Biodegradation Pathways.Genes (Basel). 2019 Jul 6;10(7):512. doi: 10.3390/genes10070512. Genes (Basel). 2019. PMID: 31284586 Free PMC article. Review.
-
Unraveling and engineering the production of 23,24-bisnorcholenic steroids in sterol metabolism.Sci Rep. 2016 Feb 22;6:21928. doi: 10.1038/srep21928. Sci Rep. 2016. PMID: 26898409 Free PMC article.
References
-
- Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991;72:1–6. - PubMed
-
- Raviglione MC, Snider DE, Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220–226. - PubMed
-
- Byarugaba DK. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105–110. - PubMed
-
- Mwinga A, Bernard Fourie P. Prospects for new tuberculosis treatment in Africa. Trop Med Int Health. 2004;9:827–832. - PubMed
-
- Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health. N Engl J Med. 2007;356:656–659. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous